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Complement activation is known to have deleterious effects on organ transplantation. On
the other hand, the complement system is also known to have an important role
in regulating immune responses. The balance between these two opposing effects is
critical in the context of transplantation. Here, we report that female mice deficient in C1q
(C1qa/) or C3 (C3/) reject male syngeneic grafts (HY incompatible) at an accelerated
rate compared with WT mice. Intranasal HY peptide administration, which induces
tolerance to syngeneic male grafts in WT mice, fails to induce tolerance in C1qa/ or
C3/ mice. The rejection of the male grafts correlated with the presence of HY DbUty
-specific CD81 T cells. Consistent with this, peptide-treated C1qa/ and C3/ female
mice rejecting male grafts exhibited more antigen-specific CD81IFN-c1 and CD81IL-101
cells compared with WT females. This suggests that accumulation of IFN-c- and IL-10-
producing T cells may play a key role in mediating the ongoing inflammatory process and
graft rejection. Interestingly, within the tolerized male skin grafts of peptide-treated WT
mice, IFN-c, C1q and C3 mRNA levels were higher compared to control female grafts.
These results suggest that C1q and C3 facilitate the induction of intranasal tolerance.
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Introduction
Most of the research undertaken so far to decipher the role of the
immune response in allograft rejection and tolerance has focused
predominantly on adaptive T-cell-mediated responses. Recently,
the role of the innate immune system in this field has been more
closely examined, following the discovery that the innate system
has a critical role in shaping the adaptive immune responses. The
complement system is an integral component of innate immunity
with well-established roles in modulation of humoral immune
responses. It has, however, become increasingly evident in recent
years that the complement system regulates antigen-specific
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T-cell responses as well [1, 2]. Complement can both enhance
T-cell immune responses to infectious agents and mediate
immunosuppression and antigen tolerance [3, 4]. As cytotoxic
effector T cells are instrumental in mediating graft rejection, it
follows that complement may impact on graft rejection via its
effect on T cells. Traditionally, complement activation is
associated with tissue injury and inflammation that occur during
graft rejection. Deposition of complement activation components
such as C3, C3d and C4d is noted in transplanted organs that
have been rejected [5, 6], but MHC-mismatched transplants also
induce antibody responses that could account for these findings.
Another common phenomenon in transplanted organs is ische-
mia/reperfusion injury that induces complement activation, which
could contribute to the pathogenic mechanisms that culminate in
graft rejection [7, 8]. Pratt et al. have elegantly demonstrated that
intrarenal production of C3 is essential for graft rejection in a renal
allograft model [9]. The above studies have mainly explored the
impact of complement on MHC-incompatible allografts. Less is
known about the role of complement, especially the components
C1q and C3, in the T-cell-only response to minor histocompatibility
disparate grafts such as HY, the male-specific minor antigens.
C1q is the first component of the classical complement pathway
and is best known for its binding to immune complexes and acti-
vation of the classical pathway [10, 11]. The classical complement
pathway converges with the alternative and lectin pathways at the
level of C3, from where effector functions of complement are
generated. Both C1q and C3 have been shown to impact on the
function of antigen presenting cells and T cells in vitro and in vivo
[12–15]. Interestingly, impaired T-cell responses are reported in
mice lacking complement in several disease models including
autoimmune disease and transplantation [16–18].
Syngeneic male skin grafts are rejected by female mice of high
responder H2b strains such as C57BL/6 (B6) and this is associated
with the development of H2-restricted cell responses by CD41 and
CD81 T cells, with rejection mediated predominantly by cytotoxic
CD81 effectors [19–23]. Prolonged survival of syngeneic male skin
grafts can be induced by intranasal administration of HY peptides
to B6 female mice [24]. Here, we report a hitherto unknown effect
of C1q and C3 on both the survival of HY-disparate skin grafts and
on the induction of transplantation tolerance to such grafts by
intranasal administration of HY peptides. Our data show that both
C1q and C3 in recipients have protective functions in the survival of
male skin grafted on female mice and are required for the induction
of tolerance following intranasal peptide administration. The
findings also suggest that the lack of C1q or C3 prevents induction
of intranasal tolerance by modulating local IFN-g production.
Results
C1q-deficient and C3-deficient female mice reject male
skin grafts faster than WT mice
To investigate the role of C1q and C3 in graft rejection, we used a
syngeneic model in which female mice were grafted with tail skin
from syngeneic male mice and the rejection of the graft was
monitored. As a control, we grafted tail skin taken from female
mice in the same graft bed as the male. When WT mice were used
as donors and recipients, while all the female recipient mice
retained the grafted female tissue indefinitely, the male grafts
were rejected with a mean survival time (MST) of 35 days. We
first evaluated whether the lack of C1q or C3 influenced the
rejection of male skin grafts. WT, C1qa/ and C3/ female
mice were grafted with WT, C1qa/ and C3/ male skin,
respectively. Control WT, C1qa/ and C3/ female skin grafts
were also placed in the same graft bed. Interestingly, C1qa/
and C3/ female mice rejected the male skin grafts significantly
faster than the WT female mice (Fig. 1A and B). The control
female skin grafts were retained indefinitely in all three groups of
mice (data not shown), indicating genetic homogeneity within
each strain, with appropriate number of backcross generations of
the mutant C1qa/ and C3/ gene-targeted strains to B6.
Rejection of allogenic skin grafts
We next evaluated whether male skin lacking C1q or C3 would
elicit a different pattern of rejection on WT female recipients than
WT male skin. WT, C1qa/ or C3/ test male and control
female tail skin grafts were given to groups of female WT mice.
WT, C1qa/ and C3/ female tail skin was co-grafted as
control. Lack of C1q or C3 in the donor skin did not significantly
influence the rate of rejection of the male grafts (data not
shown).
We then explored whether the rejection pattern of MHC-
mismatched allogenic grafts was influenced by the absence of
C1q or C3. For this purpose, B6 WT, B6.C1qa/ and B6.C3/
female mice were, respectively, given BALB/c WT, BALB/
c.C1qa/ and BALB/c.C3/ female skin grafts. As expected, the
rejection of the MHC-disparate allogenic skin graft followed a
faster time course (8–10 days) than that of syngeneic male skin
grafts. However, no differences were observed among the groups
(data not shown). In addition, we transplanted female B6 mice
with BALB/c WT, BALB/c.C1qa/ or BALB/c.C3/ female skin
grafts, and again the rejection rates of MHC-disparate allogenic
grafts were similar (data not shown).
C1q- and C3-deficient female mice fail to show
tolerance induction by intranasal HY peptide
Tolerance to male skin grafts can be induced by intranasal
administration of H2-Ab restricted Dby-encoded HY peptide to
WT mice. As previously reported [24], we administered 100 mg of
peptide intranasally to WT mice daily for 3 days. Peptide
pretreated and control untreated mice were grafted 10 days
later with syngeneic male and female WT skin. WT female mice
that received the HY peptide intranasally prior to grafting,
retained male skin grafts indefinitely (Fig. 2) while control
untreated female mice rejected the male skin with a MST of 35
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days (data not shown). In both groups of WT mice, the syngeneic
female skin grafts were retained indefinitely. In contrast, both
C1qa/ and C3/ female mice given the intranasal peptide
failed to develop tolerance to the male skin, with the grafts being
rejected with an MST of 70 and 65 days respectively (Fig. 2).
Antigen-specific tetramer-positive Uty1CD81 T cells
in circulation
The frequencies of antigen-specific CD81 T cells were evaluated
ex vivo 10wk after grafting with syngeneic male skin in the WT,
C1qa/ and C3/ females pretreated with intranasal peptide.
At this time point, the WT mice retained their test male skin
graft, whereas the complement-deficient mice had rejected
theirs. Figure 3A shows the percentage of Uty-tetramer-positive
CD81 T after HY boost by intraperitoneal injection of male spleen
cells. Before boosting, low frequencies of Uty-tetramer-positive
CD81 T cells were identified in the peripheral blood of the
peptide-treated WT and C1qa/ mice, while C3/ recipients
had slightly increased frequencies of circulating Uty-tetramer-
positive CD81 T cells (Fig. 3B). Following a booster intraperi-
toneal injection of 5 106 male spleen cells, the level
of Uty-tetramer-positive CD81 T cells in the peripheral blood
increased in both groups of complement-deficient females, but
not in the WT group (Fig. 3A and C). Control non-peptide treated
groups of females grafted with WT, C1qa/ and C3/male skin
were similarly tested before (Fig. 3D), and after boosting,
8–10wk after grafting (Fig. 3E). After injection of male spleen
cells, the levels of Uty-tetramer-positive CD81 T cells in
each group were increased, most markedly in the C1q/ mice
(Fig. 3E).
Ex vivo cytokine responses following intranasal
peptide treatment
Female mice (WT, C1qa/ and C3/) pre-treated with
intranasal peptide before being grafted with syngeneic male skin
(from WT, C1qa/ and C3/ donors, respectively) were
boosted (intraperitoneally) with syngeneic male splenocytes
12wk after grafting, at a time when mice in the WT group were
tolerant of their skin grafts, whereas the complement-deficient
mice had rejected theirs (see Fig. 2). Five days later, the mice
were sacrificed and DLN were analyzed for the presence of
antigen-specific CD81 T cells. A higher percentage of tetramer-
positive Uty1CD81 T cells was found in the DLN of C1qa/ and
C3/ mice than in WT (Fig. 4A). Moreover, following 7 days of
in vitro culture with irradiated male splenocytes, the tetramer-
positive Uty1CD81 T cells from DLN of the C1qa/ and C3/
mice exhibited a significant expansion (up to 67-fold) (Fig. 4B).
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Figure 1. Accelerated rejection of syngeneic male grafts by C1qa/
and C3/ female mice. WT, C1qa/ and C3/ female mice were
grafted with skin from WT, C1qa/ and C3/ male mice, respectively,
and graft rejection monitored. (A) Survival of syngeneic male skin
grafts transplanted on female WT (n5 17) and C1qa/ (n5 15) mice.
Data shown are pooled results from three independent experiments
(p5 0.0175). (B) Survival of syngeneic male grafts transplanted on
female WT (n5 13) and C3/ (n5 11) mice. Data shown are pooled
results from two independent experiments (p5 0.0148). Statistical
analysis was performed using the log-rank method for survival curves.
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Figure 2. Failure of induction of peptide tolerance in C1qa/ and
C3/ female mice. WT, C1qa/ and C3/ female mice were given
HYDbUty peptide (100 mg for 3 days) intranasally to induce tolerance.
Survival of syngeneic male skin grafts transplanted on peptide-treated
female WT (n5 13), C1qa/ (n5 13) and C3/ (n5 13) mice (pooled
results from two independent experiments) (WT versus C1qa/ and
WT versus C3/ mice: po0.0006). Statistical analysis was performed
using the log-rank method.
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In contrast, the Uty1CD81 T cells from DLN of WT mice failed to
expand (Fig. 4B).
The supernatants from these co-cultures of cells from the DLN
of C1qa/ and C3/ mice were found to have significantly
higher levels of IFN-g than those from WT mice (Fig. 4C).
Furthermore, intracellular staining confirmed that the CD81
T cells from the DLN and spleen cultures produced IFN-g in an
antigen-dependent manner (Fig. 4D). Interestingly, C1qa/ and
C3/ mice also displayed significantly higher percentages of
antigen induced CD81IL-101 T cells than WT mice (Fig. 4E).
Very low percentages of the CD41 T cells from the DLN or spleen
produced IL-10, but the trend observed in the three groups of
mice was similar to that of the CD81 T cells (data not shown). In
the groups of mice that had not received intranasal peptide prior
to grafting, all of which had rejected the test male skin grafts, the
percentages of CD81IL-101 T cells were found to be increased
both in the DLN and spleen of the C1qa/ and C3/ mice in
comparison with WT mice. In contrast, the percentages of CD81
IFN-g1 T cells did not differ significantly between the groups
(Supporting Information Fig. 1).
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Figure 3. HY antigen-specific Uty1CD81 T cells in peripheral blood. Female WT, C1qa/ and C3/ mice given intranasal peptide 10 days before
grafting with syngeneic male skin 10 wk previously were tail-bled before and 7 days after boosting with intraperitoneal male splenocytes. At this
time, WT mice were tolerant of their male grafts, while mice in both complement-deficient groups had rejected theirs. PBL were stained with mAb
against CD8 and with Uty tetramers. (A) FACS profiles of PBL from one mouse in each group stained ex vivo with anti-CD8 and Uty tetramers 7 days
after the intraperitoneal boost. (B, C) Percentage of CD81Uty1 T cells in PBL of each mouse in the three groups before (B), and after (C),
intraperitoneal boosting with male splenocytes. n5 6–7 each group. (D, E) Percentage of CD81Uty1 T cells in PBL of non-peptide-treated WT,
C1qa/ and C3/ mice subsequently grafted with syngeneic male skin before (n5 7 each group) and after intraperitoneal boosting (n5 9, 11, 7
respectively; pooled results of two experiments) with male splenocytes. Each symbol represents data from an individual mouse, horizontal bars
and the numbers next to the bars indicate the mean (Statistical analysis with Student’s t-test).
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Tolerized male skin grafts express increased levels of
C1q, C3 and IFN-c
We next tested whether local production of complement proteins
and IFN-g occurs following induction of tolerance. WT female
mice were given intranasal peptide and grafted with syngeneic
male and female skin. Both grafts were harvested from the
tolerized mice 1012wk after grafting and the mRNA expression
of C1q, C3 and IFN-g analyzed in the grafted skin. Tail skin from
WT female mice were used as controls. The expression of IFN-g,
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Figure 4. Ex vivo cytokine responses following intranasal peptide and skin grafting. HYAbDby peptide was administered intranasally to WT,
C1qa/ and C3/ mice followed by grafting of WT, C1qa/ and C3/ male skin respectively ten days later. Following an intraperitoneal boost
with male splenocytes 12 wk later, the mice were sacrificed and cells from DLN and spleen harvested. The cells were re-stimulated in vitro with
irradiated male splenocytes and stained with anti-CD8 mAb and Uty-tetramer. (A, B) Representative FACS profiles of Uty-tetramer and CD8 on cells
of the DLN before and after in vitro restimulation. (C) Cells isolated from DLN were co-cultured with irradiated female or male splenocytes and
IFN-g levels were quantified by ELISA. Each symbol represents data from an individual mouse as the difference in IFN-g produced following in vitro
stimulation with male splenocytes versus female splenocytes. (D) Cells isolated from the DLN and spleen were cultured in vitro with irradiated male
splenocytes and restimulated with HYDbUty-peptide-pulsed female splenocytes. IFN-g-producing CD81 T cells were quantified by intracellular
staining and flow cytometry. (E) Cells from DLN and spleen were cultured in vitro with irradiated male splenocytes and then restimulated
with HYDbUty-peptide-pulsed female splenocytes. IL-10-producing CD81 T cells were quantified by intracellular staining and flow cytometry.
(C–E) Results are pooled from two independent experiments; horizontal bars and the numbers next to the bars indicate the mean (statistical
analysis with Student’s t-test).
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C1q and C3 mRNA was found to be several fold higher in the skin
grafts compared with control female skin (C1q mRNA:
1.0370.22 female graft versus 1.4370.2 male graft, expressed
in arbitrary units; C3 mRNA: 1.9771.35 female graft versus
3.4571.84 male graft; IFN-g mRNA: 0.0470.01 female graft
versus 0.1570.57 male graft) (Fig. 5).
Discussion
The lack of complement is strongly linked with development of
autoimmune phenomena. This is particularly true for the early
components of the classical complement pathway [25, 26].
Deficiency of C1q can lead to SLE-like phenomena in both
humans and mice, suggesting that C1q is an important
contributor to maintaining self-tolerance. However, the role of
C1q in ‘‘tolerance’’ to foreign tissue remains largely unexplored.
Here, we demonstrate that C1q indeed contributes toward
tolerance induction and/or maintenance of grafted foreign tissue.
First, female mice grafted with syngeneic male skins reject their
grafts much faster in the absence of C1q. Second, intranasal
administration of HY peptide fails to induce tolerance to male
skin in the absence of C1q.
Interestingly, we also show that deficiency of C3 results in a
rapid rejection of male skin grafts, similar to that observed with
C1q deficiency. Tolerance to male grafts following intranasal
administration of HY peptide also fails to occur when C3 is
absent. This effect observed with C3 on HY mismatched trans-
plants is perhaps surprising given the previous literature on the
role of C3 in MHC-disparate allo-transplantation. Pratt et al. have
demonstrated that MHC-disparate renal allografts survive longer
in the absence of C3 [9]. Also, other studies have implicated
complement in the rejection of both MHC-mismatched allografts
and xenografts [9, 27]. In this context, it is notable that the major
difference between our observations and the previous published
data [9, 27] relate to the different nature of the grafts. Kidney [9]
and heart transplantation [27] involves grafting of a vascularized
solid organ, a very different procedure to skin grafting. Further-
more, MHC-mismatched transplants induce antibody responses
that could account for the differences observed between our
study and previous publications. In support of the hypothesis that
different experimental models underlie the differences, a
requirement for C3 in the induction of tolerance has also been
reported in some models. An up-regulation of C3 has been noted
in the transplanted rat liver following induction of tolerance [28].
Also, C3 has been shown to be involved in the suppression of a
delayed type-hypersensitivity response to antigen injected into
the anterior chamber of the eye [4].
The exact mechanism by which the failure of tolerance
induction occurs in the C1q and C3-deficient mice is yet to be
understood. Rejection of HY mismatched skin grafts is primarily a
T-cell-driven effect [29]. We have previously shown that peptide-
induced tolerance causes reduction in the number of antigen-
specific HY DbUty specific CD81 T cells, but does not eliminate
them entirely [24]. In keeping with this, an increase in HY
peptide specific CD81 T cells was noted both in the circulation
and in the DLN of peptide pretreated C1qa/ and C3/ mice
rejecting the male grafts and this appears to correlate with graft
rejection. This suggests that C1q and C3 influence the graft
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Figure 5. Up-regulation of mRNA expression of IFN-g, C1q and C3 in
tolerated male grafts. HYAbDby peptide was administered intranasally
to WT female mice followed by grafting of WT male and female
skin. The skin grafts were harvested 3 months later and analyzed
using quantitative PCR analysis of IFN-g, C1q and C3 mRNA.
Ungrafted female tail skin was used as control. The y-axis represents
an arbitrary linear scale of the mean 7 SEM mRNA products in skin
samples. The results represent pooled data from skin grafts of three
mice.
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rejection by modulating antigen-specific T cells. This is not
surprising as both C1q and C3 have been demonstrated to impact
on the function of antigen presenting cells and T cells in vitro
[12–15]. Furthermore, in our model during the induction phase
of tolerance (prior to skin grafting), the administration of peptide
does not lead to any detectable expansion of endogenous anti-
gen-specific CD41 T cells. This contrasts to administration of
peptide plus LPS (which causes accelerated graft rejection) that
expands the endogenous population of antigen-specific CD41
T cells producing both IFN-g and IL-2 [24]. Subsequent adoptive
transfer experiments, using naı¨ve antigen-specific CD41T cells,
have revealed that in peptide tolerized WT animals there is an
initial expansion of antigen-specific CD41 T cells that have
upregulated FoxP3, LAG3, CTLA4 and IFN-g (our unpublished
data). As C1q and C3 have been shown to be required for the
optimum production of IFN-g by antigen-specific T cells [12, 15],
one could hypothesize that the inadequate local IFN-g production
in C1qa/ and C3/ mice may contribute to the failure of HY
peptide to generate this population of regulatory T cells, an
hypothesis consistent with the published in vitro findings. It
would be also consistent with the finding that, following male
skin graft, the T cells accumulating in the DLN of C1q- and C3-
deficient mice that have rejected the male grafts produced more
IFN-g and, curiously, more IL-10, following in vitro restimulation
with HY peptide pulsed APC. These cytokines may just reflect the
ongoing inflammation or may directly contribute to mediate
rejection in HY-disparate grafting in the context of complement
deficiency, by supporting the expansion of CD81 effector T cells.
Our previous findings of increased numbers of antigen induced
IL-10 as well as IFN-g-producing T cells in non-tolerant controls
in comparison with HY peptide induced skin graft tolerant mice
[24] are also consistent with this. The presumption here would be
that IL-10 could be produced by Th1 cells for self-regulation.
More work will be needed to dissect the events through which a
deficiency of C1q or C3 results in the accumulation of antigen-
specific T cells in vivo. Recently, deficiency of C1q was shown to
associate with a rapid rejection of MHC-mismatched cardiac
allografts [30]. In this model, rejection was found to associate
with accelerated humoral responses to alloantigens in C1qa/
mice but not with enhanced T-cell responses.
Another possible mechanism for failure of intranasal tolerance
induction in complement-deficient mice could involve antigen
presentation per se. Induction of tolerance by intranasal adminis-
tration of the MHC class II–restricted HYAbDby peptide is likely to be
the result of peptide presentation by DC in the absence of a second
immunostimulatory signal. We and others have shown that
C1qa/ or C3/ DC are poorer than WT DC in presenting antigen
to antigen-specific T cells [12–15]. Thus, ineffective presentation of
intranasal peptide in C1q- and C3-deficient mice could prevent the
development of the antigen-specific CD41 T cells expressing regu-
latory phenotype that are thought to be required for subsequent
tolerance.
Local production of factors in the grafted tissue may also
contribute to tolerance induction. We found a relative up-regu-
lation of C1q and C3 in the male skin grafts in the tolerized
recipients compared with the female grafts. This observation is
similar to the finding that C3 is up-regulated in tolerated liver
grafts in a rat model [28]. Interestingly, local levels of IFN-g were
also found to be higher in the tolerated male skin graft compared
to the adjacent female skin graft. This is consistent with the
observation that IFN-g may have a paradoxical protective role in
context of transplantation [31]. IFN-g has been shown to
contribute to the function of regulatory T cells [32], as well as be
a protective factor in an experimental autoimmune glomeru-
lonephritis model [33]. In addition, IFN-g signaling on DC can
induce indoleamine 2,3-dioxygenase expression, and indole-
amine 2,3-dioxygenase-expressing DC can either promote the
expansion of naturally occurring regulatory T cells or convert
naı¨ve CD41 T cells into induced regulatory T cells [34]. We have
recently shown that C1q is required for the optimum production
of IFN-g by antigen-specific T cells [12, 15]. Similarly, C3 defi-
ciency associates with a decreased production of IFN-g by
T cells. Thus inadequate local IFN-g production in C1qa/ and
C3/ mice may well contribute to rapid rejection of the male
grafts and to the failure of tolerance induction with HY peptide.
These novel results highlight a new facet to complement
immunology. In addition to the tolerization to HY disparate
grafts, intranasal administration of peptide has been used to
induce tolerance in murine models of autoimmunity as well as
asthma [35, 36]. Thus the requirement of C1q and C3 for
promoting intranasal tolerance is a new finding with therapeutic
potential. Future research directed toward dissecting the
mechanisms by which complement influences the balance
between graft tolerance/rejection could firmly place complement
in the armamentarium of the transplant immunologist.
Materials and methods
Culture media and reagents
All cells were cultured in RPMI 1640 (Invitrogen Life Techno-
logies) containing 100U/mL penicillin, 100mg/mL streptomycin,
1.5mM L-glutamine and 10% heat-inactivated FBS.
Mice
BALB/c and B6 mice (8–12wk old) were purchased from Harlan
(Blackthorn, UK). B6.C1qa/ [18], B6.C3/, BALB/c.C1qa/
and BALB/c.C3/ were generated by backcrossing the original
strain onto the C57BL/6 or BALB/c genetic background for ten
generations.
Peptides and tetramers
Peptides HYAbDby, NAGFNSNRANSSRSS; HYDbUty,WMHHNM-
DLI were prepared as previously described [24]. MHC class I
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tetramers were produced using a previously described [37]
modification of the method of Altman et al. [38].
Quantitative RT-PCR
RNA was prepared from tail skin using mechanical homogeniza-
tion and TRIzol reagent (Invitrogen Life Technologies) as
previously described [39]. Test samples were assessed in
triplicate for expression of 18S ribosomal RNA and IFN-g, C1q
and C3 transcripts. Expression values were determined from
standard curves generated from each RNA preparation, plotting
cycle threshold values against log quantity. Normalized IFN-g,
C1q and C3 values were obtained by division with the
corresponding 18S value and expressed in arbitrary units.
PBL staining
Mice were tail-bled into tubes containing EDTA. Red blood cell
lysis was performed and samples centrifuged. The cells were
washed with PBS and pelleted. The pellet was resuspended in
PBS 1% FBS and incubated for 10min at 371C with CD8-FITC and
HYDbUty tetramer–PE. Cells were washed and measured using
flow cytometry.
In vitro expansion of tetramer-positive T cells isolated
from DLN
Axillary nodes from the side of grafted skin were collected and
single-cell suspensions were prepared. The DLN cells (4 106/
well) were cultured with irradiated syngeneic male spleen cells
(4106/well) and 10 IU/mL recombinant human IL-2 (hu-rIL-2)
in 24-well plates. Cultures were sampled on day 7 for tetramer-
specific T-cell analysis as above. The remaining cells were then
used for quantification of intracellular cytokines as detailed
below.
Intracellular cytokine detection/quantification
To stimulate cytokine production, splenocytes (4106/mL) or
DLN cells from graft-rejected or tolerant WT, C1qa/ and C3/
B6 females were cultured with irradiated B6 male splenocytes
(4106/mL), in the presence of hu-rIL-2 (10 IU/mL). Seven days
later, the activated T cells (2 106/mL) were re-stimulated with
irradiated unpulsed or peptide-pulsed B6 female T-cell-depleted
splenocytes (4106/mL) for 6 h in the presence of monensin
(GolgiStop; BD Biosciences Pharmingen). Cultured cells were
incubated with 2.4G2 antibody, washed and stained with anti-
CD4–PerCP and anti-CD8–PE. After washing, cells were fixed,
permeabilized with Cytofix/Cytoperm solution (BD Biosciences
Pharmingen), washed with Perm/Wash solution (BD Biosciences
Pharmingen) and resuspended in Perm/Wash solution containing
anti-IFN-g–FITC and anti-IL-10–APC or isotype-matched control
antibodies. The cells were then washed and resuspended in
staining buffer for flow cytometry analysis.
Intranasal peptide administration
PBS (20mL) containing 100mg HYAbDby peptide was administered
intranasally on three consecutive days to WT, C1qa/ and C3/
B6 female mice following anesthesia with isoflurane. Control mice
did not receive the intranasal peptide. The mice were grafted with
syngeneic male and female skin grafts 10 days later.
Skin grafting
Skin grafting was conducted by the method of Billingham and
Medawar using tail skin grafted onto the lateral thorax. After
removal of the plaster casts, grafts were observed every 2 to 3
days and scored as rejected when less than 10% viable tissue
remained [24].
ELISA
A sandwich ELISA for IFN-g was performed using purified capture
and biotinylated detection antibodies from BD-Pharmingen. The
samples and standards were added in duplicates.
Statistical analysis
Statistical analysis was performed using the two-tailed Student’s
t-test for unpaired samples with unequal variance. Probability
values (p) less than 0.05 were considered statistically significant.
Statistical analysis for survival curves was performed using the
log-rank method in GraphPad Prism version 3.02 software (San
Diego, CA, USA).
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